Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01547806 · OUTCOME

Range of Cluster of Differentiation 34 (CD34) Cells Collected

Collection of Transplant Stem Cells for Plasma Cell Myeloma · Source last updated 2018-03-07

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
MEDIAN
Unit
Number of CD34 cells per kg/BW (x 10EE6)
Interval / dispersion
Full Range
Time frame
Through Day 2 of collection

What was measured

Progenitor cells by apheresis was determined by flow cytometry.

Groups in this outcome

Hematopoietic Progenitor Cells

Subjects will undergo mobilization and collection of HPC, Apheresis for subsequent use in various clinical protocols. Filgrastim: Filgrastim will be administered as a single daily dose in a dose range of 10-16ug/kg/day subcutaneously for 5-7days Plerixafor: Plerixafor will be given on day 4, 8-10 hours before the day 5 apheresis, dose calculated according to patient weight Apheresis: The minimum cluster of differentiation 34 (CD34)+ cell dose that must be collected in order to proceed with a single autologous transplantation is 2 x 106 CD34+ cells/kg.

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Hematopoietic Progenitor Cells49

Reported measurements

Source class 1
Values in Number of CD34 cells per kg/BW (x 10EE6) · Interval/dispersion: Full Range
GroupValueSpreadLowerUpperComment
Hematopoietic Progenitor Cells6.3Not reported1.717Not reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        lower Limit
        1.7
        upper Limit
        17
        value
        6.3
denoms
  1. counts
    1. group Id
      OG000
      value
      49
    units
    Participants
description
Progenitor cells by apheresis was determined by flow cytometry.
dispersion Type
Full Range
groups
  1. description
    Subjects will undergo mobilization and collection of HPC, Apheresis for subsequent use in various clinical protocols. Filgrastim: Filgrastim will be administered as a single daily dose in a dose range of 10-16ug/kg/day subcutaneously for 5-7days Plerixafor: Plerixafor will be given on day 4, 8-10 hours before the day 5 apheresis, dose calculated according to patient weight Apheresis: The minimum cluster of differentiation 34 (CD34)+ cell dose that must be collected in order to proceed with a single autologous transplantation is 2 x 106 CD34+ cells/kg.
    id
    OG000
    title
    Hematopoietic Progenitor Cells
param Type
MEDIAN
reporting Status
POSTED
time Frame
Through Day 2 of collection
title
Range of Cluster of Differentiation 34 (CD34) Cells Collected
type
PRIMARY
unit Of Measure
Number of CD34 cells per kg/BW (x 10EE6)

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice